Guidance on the use of donepezil, rivastigmine and galantamine for the treatment of Alzheimer's disease
By: National Institute for Clinical Excellence.
Series: Technology appraisal guidance -- no. 19
Publisher: National Institute for Clinical Excellence
Published: 2001
Place of publication: London
Language: eng
Number of pages: 13
Subjects: Cholinesterase inhibitors -- Therapeutic use.; Alzheimer's disease -- Treatment.
Notes: Cover title.